Pesquisa

Optimization of the diabetes screening questionnaire for patients with psoriasis

Morzhanaeva M., Svechnikova E.

(Rus)

Volume 29, Nº 4 (2022)

Application of the diabetes screening questionnaire in patients with psoriasis

Morzhanaeva M., Svechnikova E., Shchepkina E., Kuznetsov A.

(Rus)

Volume 30, Nº 3 (2023)

Combination therapy for type 2 diabetes maintains its position. Clinical case

Podachina S., Biryukova E., Solovievа I.

(Rus)

Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus

Bagriy A., Shchukina E., Efremenko V., Mikhailichenko E., Suprun E.

(Rus)

Nº 10 (2012)

Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii

Ametov A., Valitov B., Chernikova N., Antsiferov M.

(Rus)

Adherence to modern technologies of glycemic management in diabetic patients

Chernikova N., Prokhorova K., Gancho I.

(Rus)

Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice

Antsiferov M., Zilov A., Koteshkova O., Demidov N.

(Rus)

Nº 5 (2017)

PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS

Ametov A.

(Rus)

Volume 31, Nº 2 (2024)

Treatment options for different subtypes of gestational diabetes

Davidenko I., Volkova N., Degtyareva Y.

(Rus)

Nº 11 (2012)

Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya

Mayorov A.

(Rus)

Latent autoimmune diabetes in adults: current concepts of risk factors, diagnosis, and therapy

Druk I., Safronova S., Kulebakina K.

(Rus)

Volume 29, Nº 4 (2022)

Type 3 diabetes mellitus: is there a chance to become famous?

Morgunov L.

(Rus)

Volume 31, Nº 6 (2024)

Features of macro- and microvascular complications in patients with type 2 diabetes mellitus (observational case-control study)

Bagriy A., Stefanenko A., Mikhailichenko E., Stefanenko E., Sabelnikova Y.

(Rus)

Nº 5 (2016)

GLYCEMIC VARIABILITY AS A THERAPEUTIC TARGET IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS

Ametov A., Chernikova N., Demidova T., Nazhmutdinova P.

(Rus)

Nº 3 (2012)

DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE

Peterkova V., Peterkova V.

Nº 3 (2012)

SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS

Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.

Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study

Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.

(Rus)

Volume 26, Nº 14 (2019)

Experience in the integrated use of organizational approaches and clinical tools to achieve glycemic control goals

Antsiferov M., Demidov N.

(Rus)

Potentials for the use of azilsartan and spironolactone in patients with arterial hypertension and diabetes mellitus

Ignatenko G., Bagriy A., Mikhailichenko E., Prikolota A., Mogilevskaya K., Sabelnikova Y., Belikov V.

(Rus)

Type 1 diabetes mellitus and physical activity, the possibilities of using insulin degludec: analysis of clinical cases

Elsukova O.

(Rus)

Can a glucometer with an intelligent mobile application become an alternative to continuous glycemic monitoring?

Koteshkova O., Antsiferova D., Antsiferov M.

(Rus)

News of medicine

Kudinova S.

(Rus)

Features of compensation of carbohydrate metabolism in patients with type 2 diabetes mellitus hospitalized with coronavirus infection

Markova T., Anchutina A., Stas M., Medzhidova M.

(Rus)

Volume 30, Nº 8 (2023)

Modern possibilities for correcting the uric acid level and eliminating skin manifestations of gout

Vereshchagin E., Svechnikova E., Arutyunyan G., Artemyeva N., Devyatova A., Sherf A.

(Rus)

Volume 30, Nº 3 (2023)

Problems of pancreas transplantation and the role of bioengineered materials in long-term survival and functioning of islet cells

Bulgakova S., Sharonova L., Dolgikh Y., Kosareva O., Treneva E., Kurmaev D.

(Rus)

Volume 29, Nº 11/12 (2022)

Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study

Antsiferov M., Demidov N., Safronova T., Mishra O.

(Rus)

Volume 29, Nº 4 (2022)

The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women

Apetov S., Apetova V.

(Rus)

Volume 28, Nº 12 (2021)

School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus

Lisker A., Volkova A., Chernaya M., Mozgunova V., Durdyeva M.

(Rus)

Experience of using the new ultrafast-acting insulin Fiasp® in patients on insulin pump therapy: a case report

Barsukov I., Demina A.

(Rus)

Predictors of severe course of disease and high mortality among patients with COVID-19 and diabetes mellitus

Ivanova M., Zhurtova I., Sizhazheva S., Gubachikova A.

(Rus)

Volume 27, Nº 4 (2020)

Features of the treatment of patients with type 2 diabetes mellitus and morbid obesity

Amosova M., Gurova O., Fadeev V.

(Rus)

The place of glyflozins in the management of type 2 diabetes mellitus

Sharonova L., Verbovoy A.

(Rus)

Diabetic autonomic neuropathy: problems of diagnosis and therapy

Kurnikova I., Yurovsky A.

(Rus)

Nº 11 (2018)

Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use

Biryukova E.

(Rus)

Nº 16 (2017)

Disturbances of the autonomic innervation of the cardiovascular system and hemostasis: their role in the change of microcirculation in patients with type 2 diabetes mellitus

Tsvetkova I., Kaukova A., Belyakova N., Vasyutkova O., Konovalova O., Lareva A.

(Rus)

Nº 7 (2017)

Therapy with nonsteroid antiinflammatory drugs in patients with acute nonspecific low back pain: dynamics of renal function: results of «PANDA» cogort study

Zolotovskaya I., Davydkin I., Borovkova N.

(Rus)

Nº 5 (2017)

SELF-CONTROL OF GLYCEMIA: SHELFLIFE OF TEST STRIPS IS IMPORTANT

Biryukova E.

(Rus)

Nº 16 (2016)

Diabetes mellitus and coronary artery disease: features of clinical manifestation and treatment

Verbovoy A., Sharonova L.

(Rus)

Nº 5 (2016)

INCRETIN SYSTEM AS PROMISING PHARMACOLOGICAL TARGET FOR HYPOGLYCEMIC THERAPY

Kurkin D., Volotova E., Bakulin D., Lomkina E., Tyurenkov I.

(Rus)

Nº 17 (2015)

Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy

Verbovoy A., Tsanava I., Verbovaya N.

(Rus)

Nº 9 (2015)

NEBIVOLOL V LEChENII ARTERIAL'NOY GIPERTENZII U BOL'NYKh VYSOKOGO RISKA

Minushkina L.

(Rus)

Nº 16 (2014)

Analiz effektivnosti i bezopasnosti primeneniya otechestvennogo insulina Rinsulin NPKh v gorode Nizhniy Novgorod

Zanozina O., Sorokina Y., Lovtsova L., Borovkov N.

(Rus)

Nº 5 (2014)

UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa

Antsiferov M., Koteshkova O.

(Rus)

Nº 5 (2014)

TERAPIYa LIRAGLUTIDOM ZNAChITEL'NO ULUChShAET KONTROL' GLIKEMII I OKAZYVAET POLOZhITEL'NOE VLIYaNIE NA SERDEChNO-SOSUDISTUYu SISTEMU PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA

Kudinov V., Nichitenko M., Chesnikova A.

(Rus)

Nº 16 (2013)

Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki

Chernikova N., Ametov A., Antsiferov M.

(Rus)

Nº 5 (2013)

PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa

Petunina N., Trukhina L., Sinitsyna E., Antsiferov M.

(Rus)

Nº 5 (2013)

REGIDRATATsIONNAYa TERAPIYa I VOZMOZhNOSTI EE KONTROLYa U PATsIENTOV S DIABETIChESKIMI KOMAMI (OBZOR LITERATURY)

Legun A., Vetsheva M.

(Rus)

Nº 16 (2012)

Mnogofaktornoe upravlenie sakharnym diabetom 2 tipa: kakovy nashi segodnyashnie vozmozhnosti

Galstyan G.

(Rus)

Nº 11 (2012)

Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya

Shilov A., Abdullaeva A.

(Rus)

Nº 7 (2012)

DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW

Antsiferov M., Antsiferov M.

Nº 3 (2012)

SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?

Kononenko I., Smirnova O., Smirnova O., Kononenko I.

Nº 16 (2011)

SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Petunina N., Brashchenkova A., Petunina N., Brashcenkova A.

Nº 3 (2011)

CURRENT APPROACHES TO THERAPY TYPE 2 DIABETES - EFFECT ON INSULIN RESISTANCE

Shishkova V., Shishkova V.

Nº 16 (2010)

PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES

Rudakova A., Rudakova A.

Nº 12 (2010)

AUTONOMIC NEUROPATHY IN DIABETES MELLITUS: CLINICAL MANIFESTATIONS, DIAGNOSIS AND TREATMENT

Barinov A., Novosadova M., Barinov A., Novosadova M.

Nº 3 (2010)

New possibilities for diabetic peripheral neuropathy treatment

Komelyagina E., Antsiferov M., Komelyagina E., Antsiferov M.

Variant of development of comorbid condition with late diagnosis of pancreatogenic diabetes mellitus: clinical case

Kudinova E., Davidenko I., Volkova N.

(Rus)

Evaluation of non-glycemic effects of a fixed combination of alogliptin and pioglitazone

Elsukova O., Nikitina E.

(Rus)

Analysis of the prognostic quality of mortality predictors in patients with COVID-19 and comorbid background: a retrospective study

Aramisova L., Zhurtova I., Khachmakhova E.

(Rus)

Volume 31, Nº 2 (2024)

Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice

Elsukova O., Nikitina E., Chuprova A., Kaysina O.

(Rus)

Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus

Smirnova E.

(Rus)

Volume 30, Nº 4/5 (2023)

Pharmacotherapeutic aspects of gestational diabetes mellitus against the background of impaired maternal immunity

Kazimova A., Polukhova S.

(Rus)

Volume 30, Nº 3 (2023)

Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination

Biryukova E., Shinkin M., Morozova I.

(Rus)

Volume 29, Nº 11/12 (2022)

Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus

Pavlova M.

(Rus)

Volume 28, Nº 12 (2021)

P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy

Chernikova N.

(Rus)

New possibilities of using the FreeStyle Libre Flash-glucose monitoring system. FreeStyle Libre software ecosystem in Russia

Demidov N.

(Rus)

Volume 28, Nº 3 (2021)

The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine

Kochetkov A., Pereverzev A., Ostroumova O., Gusenbekova D., Romanovsky R., Shatalova N.

(Rus)

Volume 27, Nº 12 (2020)

Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study

Mkrtumyan A., Vorobyev S., Volkova A., Vorokhobina N.

(Rus)

Volume 26, Nº 14 (2019)

Statins and the risk of diabetes: an evidence-based review

Leonova M.

(Rus)

Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia

Pereverzev A., Ostroumova O., Tkacheva O.

(Rus)

Genetic predictors of the pharmacological effects of dipeptidyl peptidase-4 inhibitors and sulfonylureas in patients with type 2 diabetes mellitus

Shorokhova P., Baranov V., Vorokhobina N., Shpilevaya O.

(Rus)

Nº 11 (2018)

Potentials for the management of cardiovascular risk in diabetic patients on insulin therapy

Galstyan G., Antsiferov M., Alekseeva Y.

(Rus)

Nº 16 (2017)

Advantages of switch to premixed insulin degludec/aspart in patients with type 2 diabetes mellitus who have not achieved an optimal control with previous insulin therapy

Elsukova O., Sobolev A.

(Rus)

Nº 6 (2017)

POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY

Statsenko M., Turkina S., Tyshchenko I., Fabritskaya S., Poletaeva L.

(Rus)

Nº 5 (2017)

EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE

Demidov N., Antsiferov M., Dorofeeva L.

(Rus)

Nº 16 (2016)

Metabolic syndrome and intestinal microbiota

Egshatyan L., Mkrtumyan A., Zvenigorodskaya L.

(Rus)

Nº 5 (2016)

APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS

Antsiferov M.

(Rus)

Nº 17 (2015)

Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa

Antsiferov M., Nikitina T., Rodionova A., Kurbatova K., Ionova T.

(Rus)

Nº 5 (2015)

Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem

Antsiferov M., Koteshkova O.

(Rus)

Nº 18 (2014)

Primenenie Aktovegina kak universal'nyy metod lecheniya oslozhneniy sakharnogo diabeta

Meleshkevich T., Luchina E., Lukashova M.

(Rus)

Nº 16 (2014)

Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa

Biryukova E.

(Rus)

Nº 5 (2014)

KLINIKA, DIAGNOSTIKA I LEChENIE DIABETIChESKOY NEYROPATII

Sharonova L., Verbovoy A., Sharonova D.

(Rus)

Nº 16 (2013)

Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov

Ushkalova E.

(Rus)

Nº 5 (2013)

PERSPEKTIVNYE STRATEGII V LEChENII DIABETIChESKOY POLINEVROPATII: ROL' ANTIOKSIDANTNOY TERAPII

Gur'eva I., Svetlova O.

(Rus)

Nº 5 (2013)

O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA

Biryukova E.

(Rus)

Nº 3 (2012)

APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS

Antsiferov M., Antsiferov M.

Nº 16 (2011)

Insulin pump - advanced menu of experienced user

Arbatskaya N., Arbatsraya N.

Nº 5 (2011)

CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Severina T., Popkova E., Trel'skaya N., Emel'yanov V., Severina T., Popkova Y., Trelskaya N., Yemelyanov V.

Nº 3 (2011)

COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS

Petunina N., Trukhina L., Petunina N., Truhina L.

Nº 16 (2010)

ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR

Antsiferov M., Morgunov L., Antsiferov M., Morgunov L.

Nº 8 (2010)

ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS

Morkovskikh N., Morkovskikh N.

Nº 3 (2010)

Advance - movement forward

Petunina N., Petunina N.

Efficacy of gosogliptin in the treatment of type 2 diabetes mellitus: a clinical case

Smirnova E.

(Rus)

Efficacy and safety of the Russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data)

Antsiferov M., Koteshkova O., Antsiferova D., Romashkina L., Golubeva Y.

(Rus)

Intestinal microbiota status in patients with type 2 diabetes mellitus depending on the presence of chronic pyelonephritis at pre-dialysis stages of chronic kidney disease – an observational case-control study

Sturov N., Popov S., Kobalava Z., Belikov I., Zhukov V., Lyapunova T., Meleshkevich T.

(Rus)

Modern aspects of detection and monitoring of preclinical stages of type 1 diabetes mellitus in children

Varlamova T., Vezikova N.

(Rus)

Volume 31, Nº 2 (2024)

Cohort study of clinical and anamnestic characteristics of patients with a combination of type 2 diabetes mellitus and irritable bowel syndrome

Suprun O., Bagriy A., Mikhailichenko E., Andreeva E., Evtushenko A., Suprun E.

(Rus)